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ABBREVIATIONS
FDG-PET 2-deoxy-2-[18F]fluoro-D-glucose
positron emission tomography
FDR False discovery rate
SWI Susceptibility weighted imaging
SWS Sturge–Weber syndrome
AIM To evaluate clinical and metabolic correlates of cerebral calcifications in children with
Sturge–Weber syndrome (SWS).
METHOD Fifteen children (11 females, four males; age range 7mo–9y, mean 4y 1mo) with
unilateral SWS underwent baseline and follow-up magnetic resonance imaging (MRI) with
susceptibility weighted imaging (SWI), glucose metabolism positron emission tomography
(PET), and neurocognitive assessment (mean follow-up 1y 8mo). Calcified brain volumes
measured on SWI were correlated with areas of abnormal glucose metabolism, seizure
variables, and cognitive function (IQ).
RESULTS Ten children had brain calcification at baseline and 11 at follow-up. Mean calcified
brain volume increased from 1.69 to 2.47cm3 (p=0.003) in these children; the rate of interval
calcified volume increase was associated with early onset of epilepsy (Spearman’s rho [rs]
=0.63, p=0.036). Calcified brain regions showed a variable degree of glucose
hypometabolism with the metabolic abnormalities often extending to non-calcified cerebral
lobes. Larger calcified brain volumes at baseline were associated with longer duration of
epilepsy (rs=0.69, p=0.004) and lower outcome IQ (rs=0.53, p=0.042).
INTERPRETATION Brain calcifications are common and progress faster in children with SWS
with early epilepsy onset, and are associated with a variable degree of hypometabolism,
which is typically more extensive than the calcified area. Higher calcified brain volumes may
indicate a risk for poorer neurocognitive outcome.
Sturge–Weber syndrome (SWS) is a sporadic neurocuta-
neous syndrome with a facial port-wine birthmark and ipsi-
lateral leptomeningeal vascular malformation in the brain.
The most common neurological symptoms include sei-
zures, hemiparesis, and visual field deficit. The intracranial
pathology in SWS is most commonly unilateral, and about
50% of children with SWS have impaired cognitive devel-
opment.1 A significant proportion of these children has
progressive cognitive decline during the early course of the
disease, but the individual course is highly variable.2 A
recent, longitudinal study identified a number of potential
clinical and electroencephalography (EEG) predictors of
neurocognitive outcome.2
Magnetic resonance imaging (MRI) is most often used
to detect intracranial involvement in SWS; conventional
MRI can demonstrate abnormal contrast-enhancing lep-
tomeningeal vessels, enlarged choroid plexus, as well as
cortical and white matter atrophy.1,3 Cerebral calcifications
are also common and can be detected by both computed
tomography and MRI.4,5 Although progressive calcification
in SWS has been demonstrated by computed tomography,4
the timing, rate, and clinical correlates of such progression
remain to be determined.
Susceptibility weighted imaging (SWI) is an MRI tech-
nique sensitive to small changes in local magnetic suscepti-
bility in the brain tissue and is used to enhance the native
contrast of different tissue types.6 When compared with
other MRI techniques, SWI has been shown to have supe-
rior sensitivity to detect calcifications and small venous
abnormalities in children with SWS.7,8 In our previous,
cross-sectional study, severe calcification on SWI was asso-
ciated with decreased perfusion in the affected SWS brain
regions.5 Calcification has also been implicated in epilepto-
genesis in brain lesions with various etiologies, including
neurocysticercosis and SWS.9,10
The main goal of the present study was to evaluate cere-
bral calcifications quantitatively in children with unilateral
SWS. We tested whether SWI is able to detect progressive
calcification during the early disease course, and we also
assessed the metabolic correlates of calcified brain regions
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using 2-deoxy-2-[18F]fluoro-D-glucose positron emission
tomography (FDG-PET). Finally, we evaluated whether
the volume of calcified brain tissue could be an imaging
marker for neurocognitive functioning.
METHOD
Participants
Fifteen children (11 females, four males; age range 7mo–
9y, mean 4y 1mo) with unilateral SWS were selected for
the study (Table SI, online supporting information) from a
pool of children enrolled in a prospective, longitudinal
neuroimaging study of children with SWS at the Chil-
dren’s Hospital of Michigan between 2004 and 2014. All
patients met the following inclusion criteria: (1) MRI evi-
dence of unilateral SWS brain involvement; (2) availability
of MRI including a good quality SWI sequence both at
baseline and at follow-up (mean follow-up 1y 8mo, range
1–3y); (3) availability of interictal FDG-PET; and (4)
detailed neurocognitive assessment. No apparent MRI
abnormalities were seen in the contralateral hemisphere in
any of the patients. The study was approved by the institu-
tional review board at Wayne State University and written
informed consent of the parent or legal guardian was
obtained.
Neuropsychological evaluation
All children underwent a comprehensive neuropsychologi-
cal assessment within 1 day of the follow-up MRI studies,
as described previously. Children from 2 years 6 months
to 7 years 3 months of age were administered the Wech-
sler Preschool and Primary Scale of Intelligence-III
(WPPSI-III), and children older than 7 years 3 months,
the Wechsler Intelligence Scales for Children-III (WISC-
III). Both Wechsler scales provide indices of global cogni-
tive functioning as expressed by IQ; for simplicity, we used
the Full-scale IQ in this study, because our previous study
in children with SWS found that Performance and Verbal
IQs show similar correlations with imaging and other clini-
cal variables but did not significantly differ by laterality of
the brain lesion.11
MRI acquisitions
MRI studies were performed on a Siemens Sonata 1.5 T or
a MAGNETOM Verio 3T scanner (Siemens Medical Solu-
tions, Erlangen, Germany) located at the Harper Hospital,
Wayne State University. Repeated images were acquired on
the same scanner in all but one patient. On both scanners,
MRI acquisition included an axial T1 3-dimensional mag-
netization prepared rapid gradient echo (1mm slice thick-
ness), an axial fluid attenuated inversion recovery, an axial
T2-weighted turbo spin-echo acquisition, SWI, followed
by post-contrast dynamic magnetic resonance perfusion-
weighted imaging and axial magnetization prepared rapid
gradient echo. SWI parameters were: (1) 1.5 T scanner:
SWI acquisition was performed with a 3-dimensional fully
balanced gradient-echo sequence with flip angle 20°; echo-
planar imaging factor 5; acquisition matrix 5129256948;
field of view 2569256996mm3; voxel size 0.590.592mm3;
TR/TE 89/40ms; bandwidth 160Hz/pixel.8 (2) 3 T scanner:
field of view 22491689128mm; base resolution 448; voxel
size 0.590.591mm3; partition number 96; TR/TE 30/
18ms; bandwidth 90 to 120Hz/pixel, 29 accelerated
GRAPPA paralleling imaging with 24 reference lines, and
6/8 partial Fourier along phase encoding.
FDG-PET acquisition
The details of FDG-PET acquisition in SWS have been
described previously.12 In brief, PET scans were acquired
within 24 hours of MRI acquisitions using an EXACT/HR
PET scanner (CTI/Siemens, Hoffman Estates, IL, USA)
or a GE Discovery STE PET/computed tomography scan-
ner (GE Medical Systems, Milwaukee, WI, USA). Both
scanners have a 15cm field of view and generate 47 image
planes with a slice thickness of 3mm. The reconstructed
image resolution was 5.5 (SD 0.35mm) at full width at
half-maximum in-plane and 6.0 (SD 0.49mm) at full width
at half-maximum in the axial direction. Scalp EEG was
monitored in all children during the tracer uptake period
and showed that all studies were interictal. Forty minutes
after 0.143mCi/kg FDG injection, a static 20-minute emis-
sion scan was acquired. Calculated attenuation correction
was applied to the images using automated threshold fits
to the sinogram data.
During both MRI and PET acquisition, children were
sedated with pentobarbital (1.5–3mcg/kg) and midazolam
(0.1–0.2mcg/kg); or by midazolam (0.1–0.2mcg/kg) fol-
lowed by dexmedetomidine (1–2mcg/kg), titrated slowly to
achieve mild to moderate sedation. In some cases, fentanyl
(1mcg/kg) was used as necessary in conjunction with either
pentobarbital or midazolam. All sedated children were con-
tinuously monitored by a pediatric nurse specialized in
sedation, and physiological parameters (heart rate, pulse
oximetry) were monitored throughout the study.
Image analysis
All SWI was processed offline using SPIN (Signal Process-
ing in NMR), an in-house software. This post-processed
SWI was used for further evaluation.6 Areas of calcification
were visualized as low-intensity (black) areas on the SWI
phase and magnitude images.8 The SWI-detected calcified
lesions were visualized and verified on corresponding
planes of computed tomography scans where available, for
comparison (Fig. 1).
Calcification volume was measured by regions of interest
placed on filtered SWI phase images manually in each
plane including all voxels consistent with calcification,
using AMIDE software (version 1.0.4; http://amide.sourcef
orge.net). This analysis was performed by a single
What this paper adds
• Brain calcifications progress faster in children with Sturge–Weber syndrome
(SWS) and early-onset epilepsy.
• Hypometabolism often extends beyond calcified brain regions.
• Calcified brain volume may be an imaging biomarker for cognitive outcome
in SWS.
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investigator (VKP) who was blinded to the clinical data of
the subjects. The total volume (mm3) of calcified brain tis-
sue in the affected hemisphere was calculated both at base-
line and follow-up.
Finally, to evaluate glucose metabolic abnormalities in
areas with and without calcification, SWI was co-registered
with corresponding FDG-PET images using Vinci soft-
ware (VINCI 3.80.0; Max Planck Institute, Cologne, Ger-
many). Lobar location(s) and severity (mild/moderate/
severe) of hypo- or hypermetabolism (compared with the
homotopic cortex in the contralateral, unaffected hemi-
sphere) were noted for each PET scan by the consensus of
two of the investigators.
Seizure frequency and EEG severity scores
Seizure frequency and EEG severity scores were deter-
mined as described previously.2 In brief, a seizure fre-
quency score was assigned to each patient based on clinical
seizures occurring during the 1-year period prior to the
imaging study. The scores were determined as follows: 0,
no seizures in the previous year; 1, one to 11 seizures per
year; 2, one to four seizures per month; 3, more than four
seizures per month. As most patients presented with focal
motor seizures, seizure type was not separately assessed.
EEG severity was scored on a scale of 0 to 3, where: 0,
normal EEG; 1, focal voltage asymmetry (with or without
slowing) without epileptiform discharges; 2, sporadic, uni-
lateral epileptiform activity (≤10/min); 3, frequent epilepti-
form activity (>10/min). The frequency of epileptiform
discharges was based on the area/side showing the highest
spike frequency.
Statistical analysis
The total hemispheric volume of calcified brain tissue on
SWI was correlated with clinical variables (age at epilepsy
onset, epilepsy duration, seizure frequency score, EEG
score, and IQ) using Spearman’s rank correlation. Monthly
rate of change in calcified volume was also calculated from
baseline and follow-up volume differences, divided by the
time interval between the two scans (in months; only in
those patients who showed calcification at follow-up) and
correlated with age at seizure onset and duration of epi-
lepsy. To control for inflated alpha in the testing of multi-
ple correlations, a false discovery rate (FDR) procedure
was employed.13 Unadjusted and FDR adjusted p-values
are presented. Differences between baseline and follow-up
calcified volume were assessed by the Wilcoxon signed-
rank test. All statistical analyses were performed using
SPSS statistics for Windows (Release 23.0; SPSS, Chicago,
IL, USA), and a p-value <0.05 was considered to be signifi-
cant.
RESULTS
Clinical correlates of baseline calcification
Ten patients (67%) had cerebral calcification detected in
the affected hemisphere on baseline SWI (see lobar loca-
tions and measured volumes in Table I); the mean volume
of these calcified regions was 1.69cm3 (standard deviation
[SD] 1.95cm3). Location and extent of the calcified areas
matched well with calcification detected by computed
tomography (see example on Fig. 1). Larger calcified brain
volume on SWI at baseline was associated with longer
duration of epilepsy at baseline (Spearman’s rho [rs]=0.69,
p=0.004, unadjusted), younger age at seizure onset
(rs=0.68, p=0.008, unadjusted), and lower IQ measured at
follow-up (rs=0.53, p=0.042, unadjusted); this latter cor-
relation only showed a trend after FDR adjustment
(p=0.070) (Table II). No correlation was found between
baseline calcified brain volume and seizure frequency
scores or EEG severity scores.
Longitudinal changes of calcified brain volume
Eleven of the 15 patients had calcification detected on fol-
low-up SWI, including one who had no visible calcification
CT SWI (MAGNITUDE) SWI (PHASE)
R L
Figure 1: Demonstration of brain calcification on computed tomography (CT) and susceptibility weighted imaging (SWI; both magnitude and phase
images are shown). The images are from a 4-year-old female (patient no. 10) with extensive right hemispheric involvement. Both CT and SWI detected
calcification in the lateral frontal and temporo-parieto-occipital cortex. [Colour figure can be viewed at wileyonlinelibrary.com].
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at baseline and a small area of new calcification 2 years
later (patient no. 5 in Table I). In these 11 children, mean
calcified brain volume increased to 2.47cm3 (SD 2.23cm3)
at follow-up (p=0.003); the monthly rate of interval calcifi-
cation volume increase varied widely across patients
(2–167mm3 per month; mean +56mm3 per month) and was
more robust in those with younger age at epilepsy onset
(rs=0.63, p=0.036, unadjusted; Table II). Larger calcified
brain volume at follow-up was associated with longer dura-
tion of epilepsy and lower outcome IQ (Table II). In con-
trast, calcified brain volume at follow-up did not correlate
with seizure frequency scores. Patient no. 3 had a third fol-
low-up MRI with SWI 10 years after the second scan and
demonstrated the continuing progression of calcification
(Fig. 2).
FDG-PET correlates of calcified areas
All 15 patients showed abnormal glucose metabolism in
the affected hemisphere, including the four children with
no calcification on SWI (Table I; Fig. 3). Altogether, all
28 calcified lobes in the affected hemispheres showed some
level of hypometabolism on PET (varying from mild to
severe; Table I, Fig. 3). In addition, abnormal glucose
metabolism (mostly mild/moderate hypometabolism)
extended beyond the calcified lobe in 6 out of 11 patients
with calcifications (details in Table I).
DISCUSSION
To our knowledge, this is the first study to document the
progression of SWS-associated brain calcification using a
quantitative MRI approach. Our findings demonstrate a
high interindividual variability of the rate of progressive
calcium build-up in affected brain regions, and show that
children with early-onset seizures are at high risk for
greater calcification volumes and faster progression. In
addition, our combined MRI/PET analysis demonstrates
that while calcified brain regions occupy a relatively lim-
ited brain volume, they commonly show metabolic abnor-
malities extending into non-calcified regions. Importantly,
the association between calcified brain volume and cogni-
tive function indicates that SWI-detected calcifications
Table I: Imaging findings of the 15 children with Sturge–Weber syndrome
Patient no.
LMA lobe(s)
on MRI
Calcification FDG-PET areas of hypometabolism
Lobes
involved
Volume at
baseline (mm3)
Volume at
follow-up (mm3) Baseline Follow-up
1 R FTPO TPO 1112 3463 Mild FTPa Mod/sev TPO; mild F
2 R FTPO F 362 578 Mild FP a Mod/sev TPO; mild/mod F
3 R TPO TP 75 1162 Mild TPO Mild TPO
4 L TPO None 0 0 Mild O Mild O
5 L P P 0 75 Mild TP Mild TP
6 L FTPO FTPO 822 2826 Mod/sev F; sev TPO Mod/sev F; sev TPO
7 L TPO TPO 861 1111 n/a Mod/sev F; sev TPO
8 R P P 194 244 Mild P Mild P
9 L FTPO TPO 5720 6876 Mild FTO; mod P Mild F; mod TPO
10 R FTPO FTPO 1893 2504 Mod/sev FTP; mild O Mod/sev FTP; mild O
11 R TO None 0 0 Mild TPO Mild TPO
12 L FTPO TPO 1175 2471 Mild TP; mod O Mod TO; mild P
13 L FP None 0 0 Mild/mod TPO Mild/mod TPO
14 L FTPO FTPO 4728 5839 Mod TPO Mod TPO; mild F
15 R TPO None 0 0 Mild/mod TPO Mod/sev TPO
aLobe showed hypermetabolism on FDG-PET. Lobes in italics indicate non-calcified lobes with glucose metabolic abnormalities. Mod, moder-
ate; sev, severe (hypometabolism); SWS, Sturge–Weber syndrome; LMA, leptomeningeal angiomatosis; MRI, magnetic resonance imaging;
FDG-PET, 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography; R, right; F, frontal; T, temporal; P, parietal; O, occipital; L, left. n/a,
Not applicable.
Table II: Spearman's rank correlations between calcification volumes an-
d clinical variables
MRI variable
(calcification
volume)
Clinical
variable
Spearman’s
q
Unadjusted
p
FDR-
adjusted
p
Baseline Epilepsy
duration 1
(n=15)
0.69 0.004 0.039
Age at onset
(n=14)
0.68 0.008 0.039
IQ (n=15) 0.53 0.042 0.070
EEG severity
(n=15)
0.41 0.127 0.182
Seizure
frequency 1
(n=14)
0.21 0.462 0.577
Follow-up Epilepsy
duration 2
(n=15)
0.56 0.028 0.070
IQ (n=15) 0.61 0.016 0.053
Seizure
frequency 2
(n=15)
0.06 0.842 0.842
Monthly rate
of volume
change
Age at
onset (n=11)
0.63 0.036 0.070
Duration of
epilepsy
(n=11)
0.14 0.679 0.754
Age at onset was not included in one child who never had seizures.
Monthly rate of calcification volume change was only calculated for
11 children who showed calcification during follow-up. MRI, mag-
netic resonance imaging; FDR, false discovery rate; EEG, electroen-
cephalogram.
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may serve as an objective imaging marker for cognitive
outcome during the early disease course.
Our group has previously reported the relation between
cortical glucose hypometabolism and cognitive functions in
children with SWS in a cross-sectional study.11 In that
cohort, the extent of overall hypometabolism showed a
negative correlation with IQ, similar to our current find-
ings with the calcified brain volume. Our MRI/PET com-
parative results in the present study, showing that
calcification is often associated with mild or moderate
hypometabolism that often extends to adjacent lobes, is
consistent with the notion that hypometabolic (but still
functional) cortex may exert a ‘nociferous’ effect on the
rest of the brain – a concept originally introduced by Pen-
field14 and supported by our previous SWS PET data.11,15
Partly preserved metabolism in calcified regions can also
explain the observation that such regions can retain lan-
guage and motor functions,16 presumably because of
remaining functional neuronal tissue. On the other hand,
our previous study11 also demonstrated a non-linear (‘U-
shaped’) curve between IQ and hemispheric extent of
severely hypometabolic cortex, where function began to
increase above 60% extent of severe hypometabolism in
the affected hemisphere. We suggested that the bottom of
the ‘U’ indicated the point at which intrahemispheric reor-
ganization switched to interhemispheric reorganization, a
notion that has received some support in the work of
others using a different model of brain injury.17,18 Taken
together, our results demonstrate that while calcified
regions can sustain some degree of metabolic activity, these
areas typically are compromised functionally, with mild/
moderate hypometabolism often extending to larger areas
thus leading to brain dysfunction and neurocognitive
impairment.
Calcium deposits in SWS can contribute to brain dam-
age through various mechanisms. Calcification is typically
perivascular, with deposits forming a sleeve encrusting
small vessels.19 Calcium concretions also may be observed
in the brain parenchyma along with gliosis in adjacent
regions with focal necrosis and dystrophic calcification.
Therefore, calcium deposits can be surrounded by areas of
neuronal damage and gliosis that may contribute to hypo-
metabolism observed on PET. In addition, the impact of
calcified areas on brain function may be enhanced by their
location in deep cortex and subcortical white matter, where
they are positioned to disrupt cortical connections. In our
previous study, severely calcified cortex was also associated
with low perfusion in the subcortical white matter.5 Hypo-
metabolism in non-calcified regions may also be caused by
mechanisms not related to calcium deposits. For example,
a recent study demonstrated that microscopic (type I or
type IIa) cortical dysplasia was common in SWS surgical
specimens even if MRI could not identify cortical develop-
mental abnormalities.20 Such mild dysplastic areas may be
hypometabolic on PET even in MRI-negative regions and
contribute to hypometabolism in the affected hemisphere.
Cortical calcium deposits are also highly epileptogenic:
accumulation of calcium phosphate crystals can raise ion-
ized calcium concentrations in the brain parenchyma (adja-
cent to neurons), thus leading to increased neuronal
excitability, focal seizures, and neuronal dysfunction.21–24
Thus, calcium deposits in the SWS brain have the
Age 21mo Age 3y Age 13y
SWI (magnitude)
SWI (phase)
Figure 2: Enlarged MRI (susceptibility weighted imaging, SWI) magnitude and phase images at baseline and follow-up in a 21-month-old male
(patient no. 3) with right posterior hemispheric involvement and minimal calcification at baseline. SWI showed progressive calcification in the right pari-
etal and temporal lobe (arrows), with calcified brain volume increasing on follow-up images at age 3 years; this patient also had a second follow-up
MRI at age 13 years, demonstrating further progression in the calcified area.
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potential for an impact on both epilepsy and neurocogni-
tive dysfunction. This effect may be diminished in areas
which progress to the point of severe atrophy with no or
minimal metabolism. Alternatively, such calcified areas may
be stabilized by pharmacological treatment. A beneficial
clinical effect on symptomatic brain calcifications has been
reported with the use of the calcium chelator etidronate, a
common drug to treat diseases of bone and calcium
metabolism.25 Although anecdotal, these pilot results may
justify clinical trials with similar drugs to alleviate SWS-
associated neurological symptoms such as seizures and
headaches in patients with massive cerebral calcifications.
MRI-detected calcified brain volume adds to the list of
clinical and imaging parameters found to have prognostic
value in our recent longitudinal study of children with
SWS.2 In that study, early seizure onset, high seizure fre-
quency, early scalp EEG abnormalities, and frontal lobe
involvement on MRI were associated with poor IQ at fol-
low-up. The current study adds calcified brain volume as a
potential imaging marker of cognitive outcome. Future
studies with a larger patient group should determine if cal-
cifications are independent prognostic imaging markers of
neurocognitive outcome in SWS.
Study limitations
Despite the prospective, longitudinal design and novel find-
ings, our study has some inherent limitations. The study
population was relatively small because of the rarity of
SWS. To address the potential issue of type I statistical
error, we calculated FDR-adjusted p-values, some of which
showed a trend but were not significant. While these trends
are of interest, we acknowledge that a final, definitive con-
clusion could only be made with a larger patient population.
This is a common issue in rare conditions and warrants the
design of multicenter studies. The age of the patients varied
widely; however, all 15 patients were tested by WPPSI-III
or WISC-III at follow-up and, therefore, outcome IQs are
comparable across the entire group. The MRI studies were
performed on two different scanners, but the same scanner
was used in all but one individual case. In addition, none of
the clinical or imaging variables differed significantly
between the two scanners (data not shown); therefore, varia-
tions in the MR scanner are unlikely to have substantially
affected the overall results. Finally, calcified brain volumes
on SWI were delineated manually. Although not operator-
independent, this procedure was performed by a single
investigator who was blinded to the clinical data. Therefore,
while slight inaccuracies in the absolute volumes may have
occurred, the overall result of the consistently progressive
progression of calcified volume and associations with clini-
cal variables should be valid.
In conclusion, our data demonstrate that cerebral calcifi-
cation is common and progressive in young children with
SWS, progressing particularly rapidly in those with early
epilepsy onset. Despite its modest overall volume, calcified
brain is often associated with larger areas of hypometabo-
lism detected by PET. Calcified brain volume may be used
as an objective MRI biomarker to assist the clinical evalua-
tion and prognostication of children with unilateral SWS.
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Figure 3: Co-registered axial susceptibility weighted imaging (SWI) phase
and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography (FDG-
PET) image planes from three patients with Sturge–Weber syndrome. (a)
Patient no. 9 had left parietal (along with temporo-occipital, not shown)
calcification (white arrows). The left parietal cortex showed moderate
hypometabolism on PET (green area, red arrow), while the non-calcified
frontal cortex showed mild hypometabolism (red arrowhead) compared
with the contralateral unaffected side. (b) Left temporo-occipital and also
frontal calcifications (white arrows) in patient no. 14. While the left tem-
poro-occipital cortex (along with the left thalamus) showed severe hypo-
metabolism (blue area, red arrow), the calcified frontal cortex showed
largely preserved glucose metabolism, except for a mild decrease in the
posterior frontal region (red arrowhead). (c) Patient no. 15 had no evi-
dence of calcification on SWI, while PET showed moderate (green area)
to severe (blue area) hypometabolism (red arrows) in the right temporo-
occipital (and also parietal, not shown) cortex.
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SUPPORTING INFORMATION
The following additional material may be found online:
Table SI: Clinical data of the 15 children with Sturge–Weber
syndrome
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